Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Haustermans

Showing results (81-90 of 285) with videos related to

Pageof 29
Sort By:
European Urology|March 27, 2022
Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012Linda G W Kerkmeijer, Floris J Pos, Uulke A van der Heide, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary resultsMaarten Lambrecht, Vincent Vandecaveye, Frederik De Keyzer, et al.
Urology|February 7, 2007
Radiotherapy for bladder cancerMichael Milosevic, Mary Gospodarowicz, Anthony Zietman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2018
Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancerPhilippe Bulens, Alice Couwenberg, Karin Haustermans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2013
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysisCharlotte Billiet, Herbert Decaluwé, Stephanie Peeters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2004
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?Olga Vrieze, Karin Haustermans, Walter De Wever, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2008
Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor modelsPierre Mahy, Marc De Bast, Tjibbe de Groot, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 25, 2026
Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric thresholdCamille Draguet, Pieter Populaire, Macarena Chocan Vera, et al.
World Journal of Surgical Oncology|May 29, 2019
Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomyLieven Depypere, Melissa Thomas, Johnny Moons, et al.
European Urology Oncology|September 28, 2019
Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate CancerCharlien Berghen, Steven Joniau, Piet Ost, et al.
Pageof 29

Showing results (81-90 of 285) with videos related to

Sort By:
Pageof 29
European Urology|March 27, 2022
Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012Linda G W Kerkmeijer, Floris J Pos, Uulke A van der Heide, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2011
Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary resultsMaarten Lambrecht, Vincent Vandecaveye, Frederik De Keyzer, et al.
Urology|February 7, 2007
Radiotherapy for bladder cancerMichael Milosevic, Mary Gospodarowicz, Anthony Zietman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2018
Development and validation of an MRI-based model to predict response to chemoradiotherapy for rectal cancerPhilippe Bulens, Alice Couwenberg, Karin Haustermans, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 9, 2013
Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysisCharlotte Billiet, Herbert Decaluwé, Stephanie Peeters, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2004
Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma?Olga Vrieze, Karin Haustermans, Walter De Wever, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 25, 2008
Comparative pharmacokinetics, biodistribution, metabolism and hypoxia-dependent uptake of [18F]-EF3 and [18F]-MISO in rodent tumor modelsPierre Mahy, Marc De Bast, Tjibbe de Groot, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|March 25, 2026
Evaluating the adaptation rates for esophageal cancer: Impact of the setup error contribution and of the dosimetric thresholdCamille Draguet, Pieter Populaire, Macarena Chocan Vera, et al.
World Journal of Surgical Oncology|May 29, 2019
Analysis of patients scheduled for neoadjuvant therapy followed by surgery for esophageal cancer, who never made it to esophagectomyLieven Depypere, Melissa Thomas, Johnny Moons, et al.
European Urology Oncology|September 28, 2019
Progression-directed Therapy for Oligoprogression in Castration-refractory Prostate CancerCharlien Berghen, Steven Joniau, Piet Ost, et al.
Pageof 29